COMPANY NAME |
REVENUES 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Q1 2025 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE A Quarter Before Q4 2024 |
Moleculin Biotech Inc |
0.00 |
0.00% |
0.00 % |
0.00 % |
Johnson and Johnson |
89,331.00 |
14.37% |
14.42% |
13.95% |
Merck and Co Inc |
63,922.00 |
10.29% |
10.23% |
9.68% |
Pfizer Inc |
62,463.00 |
10.05% |
9.03% |
11.00% |
Sanofi |
49,599.72 |
7.98% |
7.98% |
0.00% |
Eli Lilly And Company |
49,003.20 |
7.89% |
8.38% |
8.38% |
Bristol myers Squibb Company |
47,636.00 |
7.67% |
7.38% |
7.65% |
Novartis Ag |
46,660.00 |
7.51% |
7.51% |
0.00% |
Astrazeneca Plc |
45,811.00 |
7.37% |
7.37% |
0.00% |
Amgen Inc |
33,424.00 |
5.38% |
5.98% |
5.27% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
4.69% |
4.69% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
4.62% |
4.39% |
4.69% |
Teva Pharmaceutical Industries Limited |
16,617.00 |
2.67% |
2.56% |
2.62% |
Viatris Inc |
14,330.20 |
2.31% |
2.14% |
2.19% |
Regeneron Pharmaceuticals Inc |
14,085.70 |
2.27% |
1.99% |
2.35% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.79% |
1.82% |
1.80% |
Organon and Co |
6,294.00 |
1.01% |
1.00% |
0.99% |
Incyte Corporation |
4,413.23 |
0.71% |
0.69% |
0.73% |
Moderna Inc |
3,177.00 |
0.51% |
0.07% |
0.60% |
Supernus Pharmaceuticals inc |
668.00 |
0.11% |
0.10% |
0.11% |
Arvinas Inc |
426.90 |
0.07% |
0.12% |
0.04% |
Innoviva Inc |
408.35 |
0.07% |
0.05% |
0.06% |
Myovant Sciences Ltd |
379.11 |
0.06% |
0.07% |
0.06% |
Madrigal Pharmaceuticals Inc |
317.38 |
0.05% |
0.09% |
0.06% |
Mannkind Corporation |
297.60 |
0.05% |
0.05% |
0.05% |
Intercept Pharmaceuticals inc |
288.25 |
0.05% |
0.06% |
0.05% |
Legend Biotech Corporation |
285.14 |
0.05% |
0.05% |
0.00% |
Morphosys Ag |
266.87 |
0.04% |
0.04% |
0.00% |
Esperion Therapeutics Inc |
259.57 |
0.04% |
0.04% |
0.04% |
Puma Biotechnology Inc |
232.71 |
0.04% |
0.03% |
0.04% |
Adaptimmune Therapeutics Plc |
181.45 |
0.03% |
0.00% |
0.00% |
Fibrogen Inc |
180.01 |
0.03% |
0.00% |
0.00% |
Deciphera Pharmaceuticals Inc |
174.91 |
0.03% |
0.03% |
0.03% |
Arcus Biosciences Inc |
141.00 |
0.02% |
0.02% |
0.02% |
Rhythm Pharmaceuticals inc |
136.86 |
0.02% |
0.02% |
0.03% |
Alimera Sciences Inc |
98.09 |
0.02% |
0.02% |
0.01% |
Zymeworks Inc |
93.38 |
0.02% |
0.02% |
0.02% |
Y mabs Therapeutics inc |
88.66 |
0.01% |
0.01% |
0.02% |
Nurix Therapeutics Inc |
88.38 |
0.01% |
0.03% |
0.01% |
Nektar Therapeutics |
87.25 |
0.01% |
0.01% |
0.02% |
Adc Therapeutics Sa |
75.82 |
0.01% |
0.02% |
0.01% |
Alpine Immune Sciences Inc |
56.52 |
0.01% |
0.00% |
0.02% |
Journey Medical Corp |
56.24 |
0.01% |
0.01% |
0.01% |
Xoma Royalty Corporation |
42.91 |
0.01% |
0.01% |
0.01% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Sunshine Biopharma Inc |
36.23 |
0.01% |
0.01% |
0.01% |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00% |
0.00% |
Bicycle Therapeutics Plc |
25.72 |
0.00% |
0.01% |
0.00% |
Novan Inc |
24.92 |
0.00% |
0.00% |
0.01% |
Allarity Therapeutics Inc |
23.79 |
0.00% |
0.00% |
0.00% |
Capricor Therapeutics inc |
22.27 |
0.00% |
0.00% |
0.01% |
Aclaris Therapeutics Inc |
17.78 |
0.00% |
0.00% |
0.01% |
Sigilon Therapeutics Inc |
17.65 |
0.00% |
0.00% |
0.00% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Pliant Therapeutics Inc |
9.85 |
0.00% |
0.00% |
0.00% |
Xilio Therapeutics inc |
9.27 |
0.00% |
0.00% |
0.00% |
Affimed N v |
9.27 |
0.00% |
0.00% |
0.00% |
International Stem Cell Corporation |
9.09 |
0.00% |
0.00% |
0.00% |
Verrica Pharmaceuticals Inc |
7.18 |
0.00% |
0.00% |
0.00% |
Athersys Inc |
5.33 |
0.00% |
0.00% |
0.00% |
Adlai Nortye Ltd |
5.00 |
0.00% |
0.00% |
0.00% |
Salarius Pharmaceuticals inc |
4.70 |
0.00% |
0.00% |
0.00% |
Nuvalent Inc |
4.23 |
0.00% |
0.00% |
0.00% |
I mab |
3.89 |
0.00% |
0.00% |
0.00% |
Ayala Pharmaceuticals Inc |
3.74 |
0.00% |
0.00% |
0.00% |
Bolt Biotherapeutics Inc |
3.64 |
0.00% |
0.00% |
0.00% |
Reata Pharmaceuticals Inc |
3.15 |
0.00% |
0.01% |
0.00% |
Oramed Pharmaceuticals Inc |
2.70 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Ainos Inc |
2.51 |
0.00% |
0.00% |
0.00% |
Longeveron Inc |
2.23 |
0.00% |
0.00% |
0.00% |
Lumos Pharma Inc |
2.21 |
0.00% |
0.00% |
0.00% |
Oncternal Therapeutics Inc |
2.16 |
0.00% |
0.00% |
0.00% |
Ibio inc |
2.11 |
0.00% |
0.00% |
0.00% |
Immuron Limited |
1.48 |
0.00% |
0.00% |
0.00% |
Actinium Pharmaceuticals Inc |
1.46 |
0.00% |
0.00% |
0.00% |
Therapeuticsmd Inc |
1.41 |
0.00% |
0.00% |
0.00% |
An2 Therapeutics Inc |
1.35 |
0.00% |
0.00% |
0.00% |
Tff Pharmaceuticals Inc |
1.28 |
0.00% |
0.00% |
0.00% |
Soligenix inc |
0.85 |
0.00% |
0.00% |
0.00% |
Ovid Therapeutics Inc |
0.55 |
0.00% |
0.00% |
0.00% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Regen Biopharma Inc |
0.24 |
0.00% |
0.00% |
0.00% |
Adagene Inc |
0.10 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Ampio Pharmaceuticals inc |
0.05 |
0.00% |
0.00% |
0.00% |
Histogen Inc |
0.02 |
0.00% |
0.00% |
0.00% |
Oncotelic Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovaro Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Fibrobiologics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Milestone Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Atea Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Contrafect Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
89bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Medicinova Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moonlake Immunotherapeutics |
0.00 |
0.00% |
0.00% |
0.00% |
Iveric Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Kinnate Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Terns Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Prelude Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eqrx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Beigene Ltd |
0.00 |
0.00% |
0.74% |
0.00% |
Mira Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Inhibitor Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Gt Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tyme Technologies Inc. |
0.00 |
0.00% |
0.00% |
0.00% |
Effector Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biophytis Sa |
0.00 |
0.00% |
0.00% |
0.00% |
Paxmedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Phio Pharmaceuticals Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Nanoviricides inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nextcure Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Whitehawk Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Kineta Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tempest Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Enliven Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Genelux Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Quoin Pharmaceuticals Ltd |
-0.01 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
621,469.96 |
100% |
151,847.45 |
100% |
MBRX's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
MBRX's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
Note: Market share is calculated based on total revenue. To get a more accurate picture of Moleculin Biotech Inc's market divisions, geographic dispersion, segments, products, and services, visit
Moleculin Biotech Inc's Business Segment.
The list includes publicly traded companies only. More information about the sources of this report can be found
here.